Top 6 Companies in the Global Mastopexy Market

The global mastopexy market was valued at USD 1.83 Billion in 2023, driven by the increasing demand for aesthetic procedures and rising acceptance of cosmetic surgery across the globe. The market is anticipated to grow at a CAGR of 5.60% during the forecast period of 2024-2032, with the values likely to reach USD 2.99 Billion by 2032.

Mastopexy, also known as a breast lift, is a surgical procedure designed to raise and reshape sagging breasts. This procedure involves the removal of excess skin and tightening of the surrounding tissue to improve the breast's contour and restore a more youthful appearance. Mastopexy can be performed alone or in conjunction with breast augmentation, depending on the patient's needs and desired outcomes. This increasingly popular procedure is driven by various factors, including ageing, pregnancy, weight loss, and genetics, all contributing to changes in breast shape and firmness.

The global mastopexy market has been experiencing significant growth, driven by the increasing demand for aesthetic enhancement procedures and the growing awareness about breast surgeries. As more women seek solutions for breast sagging, the demand for breast lifts continues to rise. Furthermore, advancements in surgical techniques and the adoption of new technologies are contributing to the market's expansion.

The introduction of dissolvable mesh in breast lifting procedures initiated a significant trend resulting in increased adoption worldwide. For instance, in February 2020, a pioneering surgeon at Fox Chase Cancer Center in the US published positive results from using a new resorbable mesh in breast reconstruction procedures. The new mesh, Phasix, was used to reinforce the abdominal wall in patients undergoing breast reconstruction, minimizing the risk of hernias and bulges, a common issue with traditional sutures. The resorbable mesh offers the advantage of reducing long-term complications, such as infection, which are associated with permanent mesh materials like polypropylene. This innovation could significantly enhance the quality and safety of mastopexy surgeries, offering better outcomes and reducing the need for revision procedures.

Further, ongoing research into improving existing procedures is another significant trend in the market. Surgeons are continuously exploring more efficient methods to enhance the aesthetic outcomes and safety of mastopexy surgeries. Studies are investigating the use of autologous tissue for breast lifts, as well as the development of less invasive techniques to reduce recovery times and complications. In addition, surgeons are focusing on creating more personalised techniques that cater to different body types, ensuring that each patient receives the most suitable treatment for their needs.

The mastopexy market is also experiencing a surge in the development of new surgical devices and technologies aimed at improving precision during procedures. Innovations like 3D breast imaging and computer-assisted surgical systems are helping surgeons achieve better aesthetic results while ensuring higher patient safety.

Major Companies Shaping the Mastopexy Market in 2024

1.    Allergan Inc

Allergan Inc. is a global leader in medical aesthetics, including breast implants for mastopexy procedures. The company’s portfolio includes a range of implants under the Natrelle brand, offering patients high-quality solutions for breast augmentation and reconstruction. Allergan is renowned for its innovation and commitment to improving patient outcomes with a wide array of aesthetic treatments, including facial injectables and surgical implants. The company focuses on advanced breast enhancement technologies, supporting the mastopexy market with its well-established, trusted products.

2.    Mentor Word Wide LLC

Mentor Worldwide LLC, a subsidiary of Johnson & Johnson, was established in 1969 and is headquartered in Santa Barbara, California. The company is a key player in the mastopexy market, offering a variety of breast implants, including the MemoryGel and MemoryShape lines. Mentor is known for its extensive research and development in breast aesthetics, providing innovative solutions that cater to both reconstructive and cosmetic surgeries. Mentor’s products are highly regarded for their safety, durability, and aesthetic outcomes, making them a leading choice for mastopexy procedures.

3.    GC Aesthetics

GC Aesthetics® (GCA) is a prominent medical technology company focused on enhancing women's health with innovative aesthetic and reconstructive breast solutions. GCA’s portfolio includes a wide range of products aimed at improving breast aesthetics, particularly through advanced implants. In September 2024, GCA launched the YOUTHLY brand in China, introducing cutting-edge breast implants such as PERLE, Luna XT, and a new version of The Round Collection. Manufactured in France and the UK, these premium silicone implants, available through an exclusive partnership with G&S Group, are poised to drive growth in China’s mastopexy market, offering high-quality solutions to meet rising demand for breast enhancement and reconstruction procedures.

4.    Cynosure

Cynosure specialises in medical aesthetic technologies, including products for mastopexy and breast contouring. The company offers innovative solutions such as body contouring and laser treatments, as well as breast lift procedures through non-invasive technologies. Cynosure is committed to advancing the field of aesthetic surgery, providing cutting-edge equipment that enhances patient outcomes. With a strong focus on minimally invasive treatments, Cynosure’s portfolio includes devices aimed at improving both cosmetic results and patient comfort during breast surgery.

5. Polytech Health & Aesthetics

Polytech Health & Aesthetics is a leading manufacturer of breast implants, specialising in both cosmetic and reconstructive surgeries. The company’s portfolio includes a variety of breast implants for mastopexy procedures, offering patients a range of sizes, shapes, and materials for optimal aesthetic results. Polytech is known for its innovative, high-quality implants, and is committed to ensuring patient safety and satisfaction. The company operates globally, supplying trusted solutions to surgeons and patients in over 70 countries.

6. Sientra

Sientra, Inc., a prominent player in the breast reconstruction and augmentation industry, is known for its advanced portfolio of breast implants and surgical products. However, in April 2024, the company announced the sale of key assets to Tiger Aesthetics Medical, LLC for USD 42.5 million, focusing on breast reconstruction and augmentation businesses. This followed their Chapter 11 filing in February 2024. As these assets transfer to new owners, innovation in the mastopexy market is expected to evolve, impacting future growth and competition.